O	3	6	The
B-Classification_system	7	10	Age
I-Classification_system	10	11	-
I-Classification_system	11	18	Related
I-Classification_system	19	22	Eye
I-Classification_system	23	30	Disease
I-Classification_system	31	36	Study
O	37	45	severity
O	46	51	scale
O	52	55	for
B-Disease	56	59	age
I-Disease	59	60	-
I-Disease	60	67	related
I-Disease	68	75	macular
I-Disease	76	88	degeneration
O	88	89	:
B-Classification_system	90	95	AREDS
O	96	102	Report
O	103	105	No
O	105	106	.
O	107	109	17

O	111	120	Objective
O	120	121	:
O	122	124	To
O	125	132	develop
O	133	134	a
B-Diagnostic_tool	135	141	fundus
I-Diagnostic_tool	142	154	photographic
O	155	163	severity
O	164	169	scale
O	170	173	for
B-Disease	174	177	age
I-Disease	177	178	-
I-Disease	178	185	related
I-Disease	186	193	macular
I-Disease	194	206	degeneration
O	207	208	(
B-Disease	208	211	AMD
O	211	212	)
O	212	213	.

O	215	222	Methods
O	222	223	:
O	224	226	In
O	227	230	the
B-Classification_system	231	234	Age
I-Classification_system	234	235	-
I-Classification_system	235	242	Related
I-Classification_system	243	246	Eye
I-Classification_system	247	254	Disease
I-Classification_system	255	260	Study
O	260	261	,
B-Diagnostic_tool	262	274	stereoscopic
I-Diagnostic_tool	275	280	color
I-Diagnostic_tool	281	287	fundus
I-Diagnostic_tool	288	299	photographs
O	300	304	were
O	305	310	taken
O	311	313	at
O	314	322	baseline
O	322	323	,
O	324	326	at
O	327	330	the
O	331	332	2
O	332	333	-
O	333	337	year
O	338	344	follow
O	344	345	-
O	345	347	up
O	348	353	visit
O	353	354	,
O	355	358	and
O	359	367	annually
O	368	378	thereafter
O	378	379	.

B-Diagnostic_tool	380	391	Photographs
O	392	396	were
O	397	403	graded
O	404	407	for
B-Symptom	408	414	drusen
O	415	430	characteristics
O	431	432	(
O	432	436	size
O	436	437	,
O	438	442	type
O	442	443	,
O	444	448	area
O	448	449	)
O	449	450	,
B-Symptom	451	461	pigmentary
I-Symptom	462	475	abnormalities
O	476	477	(
B-Symptom	477	486	increased
I-Symptom	487	494	pigment
O	494	495	,
B-Symptom	496	510	depigmentation
O	510	511	,
B-Symptom	512	522	geographic
I-Symptom	523	530	atrophy
O	530	531	)
O	531	532	,
O	533	536	and
O	537	545	presence
O	546	548	of
B-Symptom	549	562	abnormalities
O	563	577	characteristic
O	578	580	of
B-Disease	581	592	neovascular
I-Disease	593	596	AMD
O	597	598	(
B-Symptom	598	605	retinal
I-Symptom	606	613	pigment
I-Symptom	614	624	epithelial
I-Symptom	625	635	detachment
O	635	636	,
B-Symptom	637	643	serous
I-Symptom	644	646	or
I-Symptom	647	658	hemorrhagic
I-Symptom	659	666	sensory
I-Symptom	667	674	retinal
I-Symptom	675	685	detachment
O	685	686	,
B-Symptom	687	697	subretinal
I-Symptom	698	700	or
I-Symptom	701	704	sub
I-Symptom	704	705	-
I-Symptom	705	712	retinal
I-Symptom	713	720	pigment
I-Symptom	721	731	epithelial
I-Symptom	732	742	hemorrhage
O	742	743	,
B-Symptom	744	754	subretinal
I-Symptom	755	762	fibrous
I-Symptom	763	769	tissue
O	769	770	)
O	770	771	.

B-Disease	772	780	Advanced
I-Disease	781	784	AMD
O	785	788	was
O	789	796	defined
O	797	799	as
O	800	808	presence
O	809	811	of
B-Symptom	812	813	1
I-Symptom	814	816	or
I-Symptom	817	821	more
I-Symptom	822	833	neovascular
I-Symptom	834	837	AMD
I-Symptom	838	851	abnormalities
O	851	852	,
B-Symptom	853	869	photocoagulation
I-Symptom	870	873	for
I-Symptom	874	877	AMD
O	877	878	,
O	879	881	or
B-Symptom	882	892	geographic
I-Symptom	893	900	atrophy
I-Symptom	901	910	involving
I-Symptom	911	914	the
I-Symptom	915	921	center
I-Symptom	922	924	of
I-Symptom	925	928	the
I-Symptom	929	935	macula
O	935	936	.

O	937	939	We
O	940	948	explored
O	949	961	associations
O	962	967	among
B-Anatomy	968	973	right
I-Anatomy	974	978	eyes
O	979	981	of
O	982	986	3212
O	987	999	participants
O	1000	1007	between
O	1008	1016	severity
O	1017	1019	of
B-Symptom	1020	1026	drusen
O	1027	1042	characteristics
O	1043	1046	and
B-Symptom	1047	1057	pigmentary
I-Symptom	1058	1071	abnormalities
O	1072	1074	at
O	1075	1083	baseline
O	1084	1087	and
O	1088	1099	development
O	1100	1102	of
B-Disease	1103	1111	advanced
I-Disease	1112	1115	AMD
O	1116	1122	within
O	1123	1124	5
O	1125	1130	years
O	1131	1133	of
O	1134	1140	follow
O	1140	1141	-
O	1141	1143	up
O	1143	1144	.

O	1146	1153	Results
O	1153	1154	:
O	1155	1156	A
O	1157	1158	9
O	1158	1159	-
O	1159	1163	step
O	1164	1172	severity
O	1173	1178	scale
O	1179	1183	that
O	1184	1192	combines
O	1193	1194	a
O	1195	1196	6
O	1196	1197	-
O	1197	1201	step
B-Symptom	1202	1208	drusen
O	1209	1213	area
O	1214	1219	scale
O	1220	1224	with
O	1225	1226	a
O	1227	1228	5
O	1228	1229	-
O	1229	1233	step
B-Symptom	1234	1244	pigmentary
I-Symptom	1245	1256	abnormality
O	1257	1262	scale
O	1263	1266	was
O	1267	1276	developed
O	1276	1277	,
O	1278	1280	on
O	1281	1286	which
O	1287	1290	the
O	1291	1292	5
O	1292	1293	-
O	1293	1297	year
O	1298	1302	risk
O	1303	1305	of
B-Disease	1306	1314	advanced
I-Disease	1315	1318	AMD
O	1319	1328	increased
O	1329	1342	progressively
O	1343	1347	from
O	1348	1352	less
O	1353	1357	than
O	1358	1359	1
O	1359	1360	%
O	1361	1363	in
O	1364	1368	step
O	1369	1370	1
O	1371	1373	to
O	1374	1379	about
O	1380	1382	50
O	1382	1383	%
O	1384	1386	in
O	1387	1391	step
O	1392	1393	9
O	1393	1394	.

O	1395	1400	Among
O	1401	1404	the
O	1405	1408	334
B-Anatomy	1409	1413	eyes
O	1414	1418	that
O	1419	1422	had
O	1423	1425	at
O	1426	1431	least
O	1432	1433	a
O	1434	1435	3
O	1435	1436	-
O	1436	1440	step
O	1441	1452	progression
O	1453	1455	on
O	1456	1459	the
O	1460	1465	scale
O	1466	1473	between
O	1474	1477	the
O	1478	1486	baseline
O	1487	1490	and
O	1491	1492	5
O	1492	1493	-
O	1493	1497	year
O	1498	1504	visits
O	1504	1505	,
O	1506	1512	almost
O	1513	1517	half
O	1518	1524	showed
O	1525	1533	stepwise
O	1534	1545	progression
O	1546	1553	through
O	1554	1565	intervening
O	1566	1574	severity
O	1575	1581	levels
O	1582	1584	at
O	1585	1596	intervening
O	1597	1603	visits
O	1603	1604	.

O	1605	1614	Replicate
O	1615	1623	gradings
O	1624	1630	showed
O	1631	1640	agreement
O	1641	1647	within
O	1648	1649	1
O	1650	1654	step
O	1655	1657	on
O	1658	1661	the
O	1662	1667	scale
O	1668	1670	in
O	1671	1673	87
O	1673	1674	%
O	1675	1677	of
B-Anatomy	1678	1682	eyes
O	1682	1683	.

O	1685	1696	Conclusions
O	1696	1697	:
O	1698	1701	The
O	1702	1707	scale
O	1708	1716	provides
O	1717	1727	convenient
O	1728	1732	risk
O	1733	1743	categories
O	1744	1747	and
O	1748	1751	has
O	1752	1762	acceptable
O	1763	1778	reproducibility
O	1778	1779	.

O	1780	1791	Progression
O	1792	1797	along
O	1798	1800	it
O	1801	1804	may
O	1805	1810	prove
O	1811	1813	to
O	1814	1816	be
O	1817	1823	useful
O	1824	1826	as
O	1827	1828	a
O	1829	1838	surrogate
O	1839	1842	for
O	1843	1854	progression
O	1855	1857	to
B-Disease	1858	1866	advanced
I-Disease	1867	1870	AMD
O	1870	1871	.
